BindingDB logo
myBDB logout

Patent code US10287301

Compile Data Set for Download or QSAR

Found 719 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Complement factor D


(Homo sapiens (Human))
BDBM386617
PNG
((2S,4R)-1-(2-(3- acetyl-5-(2- aminopyrimidin- 5-yl...)
Show SMILES CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)c2F)c2ccc(cc12)-c1cnc(N)nc1
Show InChI InChI=1S/C27H22F5N7O4/c1-13(40)24-17-7-14(15-9-34-26(33)35-10-15)5-6-19(17)39(37-24)12-22(41)38-11-16(28)8-20(38)25(42)36-18-3-2-4-21(23(18)29)43-27(30,31)32/h2-7,9-10,16,20H,8,11-12H2,1H3,(H,36,42)(H2,33,34,35)/t16-,20+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386628
PNG
((2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-y...)
Show SMILES CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(n2)C2CC2)c2ccc(cc12)-c1cnc(C)nc1
Show InChI InChI=1S/C29H28FN7O3/c1-16(38)28-22-10-19(20-12-31-17(2)32-13-20)8-9-24(22)37(35-28)15-27(39)36-14-21(30)11-25(36)29(40)34-26-5-3-4-23(33-26)18-6-7-18/h3-5,8-10,12-13,18,21,25H,6-7,11,14-15H2,1-2H3,(H,33,34,40)/t21-,25+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386632
PNG
((2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-y...)
Show SMILES COc1cccc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)n1
Show InChI InChI=1S/C27H26FN7O4/c1-15(36)26-20-9-17(18-11-29-16(2)30-12-18)7-8-21(20)35(33-26)14-25(37)34-13-19(28)10-22(34)27(38)32-23-5-4-6-24(31-23)39-3/h4-9,11-12,19,22H,10,13-14H2,1-3H3,(H,31,32,38)/t19-,22+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386411
PNG
((2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-y...)
Show SMILES CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)n2)c2ccc(cc12)-c1cnc(C)nc1
Show InChI InChI=1S/C27H23F4N7O4/c1-14(39)25-19-8-16(17-10-32-15(2)33-11-17)6-7-20(19)38(36-25)13-24(40)37-12-18(28)9-21(37)26(41)35-22-4-3-5-23(34-22)42-27(29,30)31/h3-8,10-11,18,21H,9,12-13H2,1-2H3,(H,34,35,41)/t18-,21+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM351986
PNG
(1-(2-((2S,4R)-2-(6- bromopyridin-2- ylcarbamoyl)-4...)
Show SMILES NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cncnc1
Show InChI InChI=1/C24H20BrFN8O3/c25-19-2-1-3-20(30-19)31-24(37)18-7-15(26)10-33(18)21(35)11-34-17-5-4-13(14-8-28-12-29-9-14)6-16(17)22(32-34)23(27)36/h1-6,8-9,12,15,18H,7,10-11H2,(H2,27,36)(H,30,31,37)/t15-,18+/s2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM351992
PNG
(1-(2-((1R,3S,5R)-3-(6- bromopyridin-2- ylcarbamoyl...)
Show SMILES NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(nc1)N1CCCC1
Show InChI InChI=1/C29H28BrN9O3/c30-23-4-3-5-24(34-23)35-28(42)22-12-17-11-21(17)39(22)25(40)15-38-20-7-6-16(10-19(20)26(36-38)27(31)41)18-13-32-29(33-14-18)37-8-1-2-9-37/h3-7,10,13-14,17,21-22H,1-2,8-9,11-12,15H2,(H2,31,41)(H,34,35,42)/t17-,21-,22+/s2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM351994
PNG
(1-(2-((lR,3S,5R)-3-(2'- chloro-2- fluorobiphenyl-3...)
Show SMILES NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1ccc(F)nc1
Show InChI InChI=1/C33H25ClF2N6O3/c34-23-6-2-1-4-20(23)21-5-3-7-24(30(21)36)39-33(45)27-14-19-13-26(19)42(27)29(43)16-41-25-10-8-17(18-9-11-28(35)38-15-18)12-22(25)31(40-41)32(37)44/h1-12,15,19,26-27H,13-14,16H2,(H2,37,44)(H,39,45)/t19-,26-,27+/s2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM352000
PNG
(1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- y...)
Show SMILES NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2cnc(cc12)-c1cncnc1
Show InChI InChI=1/C30H23ClF2N8O3/c31-21-6-2-1-4-18(21)19-5-3-7-22(27(19)33)38-30(44)24-8-17(32)13-40(24)26(42)14-41-25-12-37-23(16-10-35-15-36-11-16)9-20(25)28(39-41)29(34)43/h1-7,9-12,15,17,24H,8,13-14H2,(H2,34,43)(H,38,44)/t17-,24+/s2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM354158
PNG
(1-(2-((2S,4R)-2-(3- chloro-5- fluorobenzylcarbamoy...)
Show SMILES NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cc(F)cc(Cl)c2)c2ccc(cc12)-c1ccnnc1
Show InChI InChI=1/C26H22ClF2N7O3/c27-17-5-14(6-18(28)8-17)10-31-26(39)22-9-19(29)12-35(22)23(37)13-36-21-2-1-15(16-3-4-32-33-11-16)7-20(21)24(34-36)25(30)38/h1-8,11,19,22H,9-10,12-13H2,(H2,30,38)(H,31,39)/t19-,22+/s2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM354180
PNG
((2S,4R)-1-(2-(3-acetyl- 5-(2-fluoropyrimidin-5- yl...)
Show SMILES CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(F)nc1
Show InChI InChI=1/C26H21BrF2N6O3/c1-14(36)19-12-34(20-6-5-15(7-18(19)20)16-9-30-26(29)31-10-16)13-24(37)35-11-17(28)8-21(35)25(38)33-23-4-2-3-22(27)32-23/h2-7,9-10,12,17,21H,8,11,13H2,1H3,(H,32,33,38)/t17-,21+/s2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM354181
PNG
((2S,4R)-1-(2-(3-acetyl- 5-(2-methylpyrimidin- 5-yl...)
Show SMILES CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1
Show InChI InChI=1/C27H24BrFN6O3/c1-15(36)21-13-34(22-7-6-17(8-20(21)22)18-10-30-16(2)31-11-18)14-26(37)35-12-19(29)9-23(35)27(38)33-25-5-3-4-24(28)32-25/h3-8,10-11,13,19,23H,9,12,14H2,1-2H3,(H,32,33,38)/t19-,23+/s2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386161
PNG
((2S,4R)-1-(2-(3- acetyl-5-(pyridazin- 4-yl)-1H-ind...)
Show SMILES CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc(F)c(c2)-c2nnc3CCCCCn23)c2ccc(cc12)-c1ccnnc1
Show InChI InChI=1S/C34H32F2N8O3/c1-20(45)27-18-42(29-9-6-21(13-25(27)29)22-10-11-37-38-16-22)19-32(46)44-17-23(35)14-30(44)34(47)39-24-7-8-28(36)26(15-24)33-41-40-31-5-3-2-4-12-43(31)33/h6-11,13,15-16,18,23,30H,2-5,12,14,17,19H2,1H3,(H,39,47)/t23-,30+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM354196
PNG
((2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- ind...)
Show SMILES CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(ns2)-c2ccccc2Cl)c2ccc(cc12)-c1ccnnc1
Show InChI InChI=1/C29H23ClFN7O3S/c1-16(39)22-14-37(24-7-6-17(10-21(22)24)18-8-9-32-33-12-18)15-26(40)38-13-19(31)11-25(38)28(41)35-29-34-27(36-42-29)20-4-2-3-5-23(20)30/h2-10,12,14,19,25H,11,13,15H2,1H3,(H,34,35,36,41)/t19-,25+/s2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM354220
PNG
((2S,4R)-1-(2-(5-(2- acetamidopyrimidin-5- yl)-3-ac...)
Show SMILES CC(=O)Nc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)cc(C(C)=O)c2c1
Show InChI InChI=1/C28H25BrFN7O4/c1-15(38)21-13-36(22-7-6-17(8-20(21)22)18-10-31-28(32-11-18)33-16(2)39)14-26(40)37-12-19(30)9-23(37)27(41)35-25-5-3-4-24(29)34-25/h3-8,10-11,13,19,23H,9,12,14H2,1-2H3,(H,34,35,41)(H,31,32,33,39)/t19-,23+/s2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM354272
PNG
((2S,4R)-1-(2-(3-acetyl- 5-(2-(methylamino) pyrimid...)
Show SMILES CNc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(c3F)-c3ccccc3Cl)cc(C(C)=O)c2c1
Show InChI InChI=1/C34H29ClF2N6O3/c1-19(44)26-17-42(29-11-10-20(12-25(26)29)21-14-39-34(38-2)40-15-21)18-31(45)43-16-22(36)13-30(43)33(46)41-28-9-5-7-24(32(28)37)23-6-3-4-8-27(23)35/h3-12,14-15,17,22,30H,13,16,18H2,1-2H3,(H,41,46)(H,38,39,40)/t22-,30+/s2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386259
PNG
((1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5...)
Show SMILES CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)nc1
Show InChI InChI=1S/C34H28ClFN6O3/c1-18(43)33-25-12-20(22-15-37-19(2)38-16-22)10-11-28(25)41(40-33)17-31(44)42-29-13-21(29)14-30(42)34(45)39-27-9-5-7-24(32(27)36)23-6-3-4-8-26(23)35/h3-12,15-16,21,29-30H,13-14,17H2,1-2H3,(H,39,45)/t21-,29-,30+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386268
PNG
((2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- y...)
Show SMILES CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2cc(ccc2Cl)C(N)=O)c2ccc(cc12)-c1cnc(C)nc1
Show InChI InChI=1S/C34H28ClF2N7O4/c1-17(45)32-25-10-19(21-13-39-18(2)40-14-21)7-9-28(25)44(42-32)16-30(46)43-15-22(36)12-29(43)34(48)41-27-5-3-4-23(31(27)37)24-11-20(33(38)47)6-8-26(24)35/h3-11,13-14,22,29H,12,15-16H2,1-2H3,(H2,38,47)(H,41,48)/t22-,29+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386298
PNG
(2-(2-(3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-ind...)
Show SMILES CC(=O)c1cn(CC(=O)N2NCCC2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)nc1
Show InChI InChI=1S/C33H28ClFN6O3/c1-19(42)26-17-40(29-11-10-21(14-25(26)29)22-15-36-20(2)37-16-22)18-31(43)41-30(12-13-38-41)33(44)39-28-9-5-7-24(32(28)35)23-6-3-4-8-27(23)34/h3-11,14-17,30,38H,12-13,18H2,1-2H3,(H,39,44)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386316
PNG
((2S,4R)-1-(2-(3- acetyl-5- (imidazo[1,2- a]pyrimid...)
Show SMILES CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc2ncccn12
Show InChI InChI=1S/C27H22BrFN8O3/c1-15(38)25-18-10-16(21-12-31-27-30-8-3-9-35(21)27)6-7-19(18)37(34-25)14-24(39)36-13-17(29)11-20(36)26(40)33-23-5-2-4-22(28)32-23/h2-10,12,17,20H,11,13-14H2,1H3,(H,32,33,40)/t17-,20+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386318
PNG
((2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- y...)
Show SMILES CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(F)n2)c2ccc(cc12)-c1cnc(C)nc1
Show InChI InChI=1S/C26H23F2N7O3/c1-14(36)25-19-8-16(17-10-29-15(2)30-11-17)6-7-20(19)35(33-25)13-24(37)34-12-18(27)9-21(34)26(38)32-23-5-3-4-22(28)31-23/h3-8,10-11,18,21H,9,12-13H2,1-2H3,(H,31,32,38)/t18-,21+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386345
PNG
((2S,4R)-1-(2-(3- acetyl-5-(2- isopropylpyrazolo [1...)
Show SMILES CC(C)c1cc2ncc(cn2n1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(C)=O)c2c1
Show InChI InChI=1S/C30H28BrFN8O3/c1-16(2)22-11-27-33-12-19(13-40(27)36-22)18-7-8-23-21(9-18)29(17(3)41)37-39(23)15-28(42)38-14-20(32)10-24(38)30(43)35-26-6-4-5-25(31)34-26/h4-9,11-13,16,20,24H,10,14-15H2,1-3H3,(H,34,35,43)/t20-,24+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386347
PNG
((2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- ...)
Show SMILES CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)c2F)c2ccc(cc12)-c1cnc2cc(C)nn2c1
Show InChI InChI=1S/C31H25F5N6O4/c1-16-8-27-37-11-19(12-42(27)39-16)18-6-7-24-21(9-18)22(17(2)43)14-40(24)15-28(44)41-13-20(32)10-25(41)30(45)38-23-4-3-5-26(29(23)33)46-31(34,35)36/h3-9,11-12,14,20,25H,10,13,15H2,1-2H3,(H,38,45)/t20-,25+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386357
PNG
((S)-1-(2-(3-acetyl- 5-(2- methylpyrimidin-5- yl)-1...)
Show SMILES CC(=O)c1nn(CC(=O)N2CC=C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)nc1
Show InChI InChI=1S/C33H26ClFN6O3/c1-19(42)32-25-15-21(22-16-36-20(2)37-17-22)12-13-28(25)41(39-32)18-30(43)40-14-6-11-29(40)33(44)38-27-10-5-8-24(31(27)35)23-7-3-4-9-26(23)34/h3-13,15-17,29H,14,18H2,1-2H3,(H,38,44)/t29-/m0/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386359
PNG
(6-(3-acetyl-1-(2- ((2S,4R)-2-(6- bromopyridin-2- y...)
Show SMILES CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc2cc(nn2c1)C(N)=O
Show InChI InChI=1S/C28H23BrFN9O4/c1-14(40)26-18-7-15(16-10-32-24-9-19(27(31)42)35-39(24)11-16)5-6-20(18)38(36-26)13-25(41)37-12-17(30)8-21(37)28(43)34-23-4-2-3-22(29)33-23/h2-7,9-11,17,21H,8,12-13H2,1H3,(H2,31,42)(H,33,34,43)/t17-,21+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386363
PNG
((2S,4R)-N1-(1- acetyl-6-(2- methylpyrimidin-5- yl)...)
Show SMILES CC(=O)n1cc(NC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1
Show InChI InChI=1S/C26H23BrFN7O3/c1-14-29-10-17(11-30-14)16-6-7-19-20(13-34(15(2)36)21(19)8-16)31-26(38)35-12-18(28)9-22(35)25(37)33-24-5-3-4-23(27)32-24/h3-8,10-11,13,18,22H,9,12H2,1-2H3,(H,31,38)(H,32,33,37)/t18-,22+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386367
PNG
((2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- ...)
Show SMILES CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc2cc(C)nn2c1
Show InChI InChI=1S/C35H28ClF2N7O3/c1-19-12-31-39-15-22(16-45(31)41-19)21-10-11-29-26(13-21)34(20(2)46)42-44(29)18-32(47)43-17-23(37)14-30(43)35(48)40-28-9-5-7-25(33(28)38)24-6-3-4-8-27(24)36/h3-13,15-16,23,30H,14,17-18H2,1-2H3,(H,40,48)/t23-,30+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386372
PNG
((2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- ...)
Show SMILES CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(n2)C(F)(F)F)c2ccc(cc12)-c1cnc2cc(C)nn2c1
Show InChI InChI=1S/C30H25F4N7O3/c1-16-8-27-35-11-19(12-41(27)38-16)18-6-7-23-21(9-18)22(17(2)42)14-39(23)15-28(43)40-13-20(31)10-24(40)29(44)37-26-5-3-4-25(36-26)30(32,33)34/h3-9,11-12,14,20,24H,10,13,15H2,1-2H3,(H,36,37,44)/t20-,24+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386384
PNG
((2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- ...)
Show SMILES CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(n2)C(F)(F)F)c2ccc(cc12)-c1cnc2cc(C)nn2c1
Show InChI InChI=1S/C28H23F4N9O3/c1-14-5-24-34-8-17(11-41(24)37-14)16-3-4-20-19(6-16)26(15(2)42)38-40(20)13-25(43)39-12-18(29)7-21(39)27(44)36-23-10-33-9-22(35-23)28(30,31)32/h3-6,8-11,18,21H,7,12-13H2,1-2H3,(H,35,36,44)/t18-,21+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386398
PNG
((2S,4R)-1-(2-(3- acetyl-6-hydroxy-5- (2-methylpyri...)
Show SMILES CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2cc(O)c(cc12)-c1cnc(C)nc1
Show InChI InChI=1S/C27H24BrFN6O4/c1-14(36)20-12-34(21-8-23(37)18(7-19(20)21)16-9-30-15(2)31-10-16)13-26(38)35-11-17(29)6-22(35)27(39)33-25-5-3-4-24(28)32-25/h3-5,7-10,12,17,22,37H,6,11,13H2,1-2H3,(H,32,33,39)/t17-,22+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386404
PNG
((2S,4R)-1-(2-(3- acetyl-5-(2- (((3R,3aR,6R,6aR)-6-...)
Show SMILES CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(O[C@@H]2CO[C@@H]3[C@H](O)CO[C@H]23)nc1
Show InChI InChI=1S/C32H30BrFN6O7/c1-16(41)21-12-39(13-28(43)40-11-19(34)8-23(40)31(44)38-27-4-2-3-26(33)37-27)22-6-5-17(7-20(21)22)18-9-35-32(36-10-18)47-25-15-46-29-24(42)14-45-30(25)29/h2-7,9-10,12,19,23-25,29-30,42H,8,11,13-15H2,1H3,(H,37,38,44)/t19-,23+,24-,25-,29-,30-/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386433
PNG
((2S,4R)-1-(2-(3- acetyl-5-(2- (cyclopropylamino) p...)
Show SMILES CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(NC2CC2)nc1
Show InChI InChI=1S/C28H26BrFN8O3/c1-15(39)26-20-9-16(17-11-31-28(32-12-17)33-19-6-7-19)5-8-21(20)38(36-26)14-25(40)37-13-18(30)10-22(37)27(41)35-24-4-2-3-23(29)34-24/h2-5,8-9,11-12,18-19,22H,6-7,10,13-14H2,1H3,(H,31,32,33)(H,34,35,41)/t18-,22+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386436
PNG
((2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-y...)
Show SMILES CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc(cc(Br)n2)C(F)(F)F)c2ccc(cc12)-c1cnc(C)nc1
Show InChI InChI=1S/C27H22BrF4N7O3/c1-13(40)25-19-5-15(16-9-33-14(2)34-10-16)3-4-20(19)39(37-25)12-24(41)38-11-18(29)8-21(38)26(42)36-23-7-17(27(30,31)32)6-22(28)35-23/h3-7,9-10,18,21H,8,11-12H2,1-2H3,(H,35,36,42)/t18-,21+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386443
PNG
((2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-y...)
Show SMILES CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccnc(OCC(F)(F)F)n2)c2ccc(cc12)-c1cnc(C)nc1
Show InChI InChI=1S/C27H24F4N8O4/c1-14(40)24-19-7-16(17-9-33-15(2)34-10-17)3-4-20(19)39(37-24)12-23(41)38-11-18(28)8-21(38)25(42)35-22-5-6-32-26(36-22)43-13-27(29,30)31/h3-7,9-10,18,21H,8,11-13H2,1-2H3,(H,32,35,36,42)/t18-,21+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386463
PNG
((2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-y...)
Show SMILES CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc(C)c(Br)n2)c2ccc(cc12)-c1cnc(C)nc1
Show InChI InChI=1S/C27H25BrFN7O3/c1-14-4-7-23(32-26(14)28)33-27(39)22-9-19(29)12-35(22)24(38)13-36-21-6-5-17(18-10-30-16(3)31-11-18)8-20(21)25(34-36)15(2)37/h4-8,10-11,19,22H,9,12-13H2,1-3H3,(H,32,33,39)/t19-,22+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386465
PNG
((2S)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-...)
Show SMILES CC(=O)c1nn(CC(=O)N2CC(F)(CN)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1
Show InChI InChI=1S/C27H26BrFN8O3/c1-15(38)25-19-8-17(18-10-31-16(2)32-11-18)6-7-20(19)37(35-25)12-24(39)36-14-27(29,13-30)9-21(36)26(40)34-23-5-3-4-22(28)33-23/h3-8,10-11,21H,9,12-14,30H2,1-2H3,(H,33,34,40)/t21-,27?/m0/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386470
PNG
((2S,4R)-1-(2-(3- acetyl-5-(2- (aminomethyl) pyrimi...)
Show SMILES CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(CN)nc1
Show InChI InChI=1S/C26H24BrFN8O3/c1-14(37)25-18-7-15(16-10-30-23(9-29)31-11-16)5-6-19(18)36(34-25)13-24(38)35-12-17(28)8-20(35)26(39)33-22-4-2-3-21(27)32-22/h2-7,10-11,17,20H,8-9,12-13,29H2,1H3,(H,32,33,39)/t17-,20+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386678
PNG
((1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- ...)
Show SMILES CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCc2cccc(Cl)c2F)c2ccc(cc12)-c1cnc(C)nc1
Show InChI InChI=1S/C30H28ClFN6O3/c1-16(39)28-21-9-18(20-13-33-17(2)34-14-20)7-8-23(21)37(36-28)15-26(40)38-24(10-30(3)11-25(30)38)29(41)35-12-19-5-4-6-22(31)27(19)32/h4-9,13-14,24-25H,10-12,15H2,1-3H3,(H,35,41)/t24-,25+,30-/m0/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386686
PNG
((1R,2S,5S)-3-(2- (3-acetyl-5-(2- aminopyrimidin- 5...)
Show SMILES CC(=O)c1nn(CC(=O)N2C[C@H]3C[C@H]3[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(N)nc1
Show InChI InChI=1S/C27H25BrN8O3/c1-13-3-6-21(28)32-25(13)33-26(39)24-18-8-16(18)11-35(24)22(38)12-36-20-5-4-15(17-9-30-27(29)31-10-17)7-19(20)23(34-36)14(2)37/h3-7,9-10,16,18,24H,8,11-12H2,1-2H3,(H2,29,30,31)(H,32,33,39)/t16-,18-,24+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386703
PNG
((2S,4R)-1-(2-(3- acetyl-5-(2- cyclopropylpyrazolo[...)
Show SMILES CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(cc12)-c1ccc2cc(nn2c1)C1CC1
Show InChI InChI=1S/C30H26BrFN8O3/c1-16(41)29-22-8-18(19-4-6-21-10-23(17-2-3-17)36-39(21)13-19)5-7-24(22)40(37-29)15-28(42)38-14-20(32)9-25(38)30(43)35-27-12-33-11-26(31)34-27/h4-8,10-13,17,20,25H,2-3,9,14-15H2,1H3,(H,34,35,43)/t20-,25+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386402
PNG
((2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- ...)
Show SMILES CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc(C)cc(Br)n2)c2ccc(cc12)-c1cnc2cc(C)nn2c1
Show InChI InChI=1S/C29H26BrFN8O3/c1-15-6-24(30)33-25(7-15)34-29(42)23-10-20(31)13-37(23)27(41)14-38-22-5-4-18(9-21(22)28(36-38)17(3)40)19-11-32-26-8-16(2)35-39(26)12-19/h4-9,11-12,20,23H,10,13-14H2,1-3H3,(H,33,34,42)/t20-,23+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386712
PNG
((1R,3S,5R)-2-(2- (3-acetyl-5- (pyrazolo[1,5- a]pyr...)
Show SMILES CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(cc12)-c1cnc2ccnn2c1
Show InChI InChI=1S/C27H22BrN9O3/c1-14(38)26-18-6-15(17-9-30-24-4-5-31-36(24)12-17)2-3-19(18)35(34-26)13-25(39)37-20-7-16(20)8-21(37)27(40)33-23-11-29-10-22(28)32-23/h2-6,9-12,16,20-21H,7-8,13H2,1H3,(H,32,33,40)/t16-,20-,21+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386721
PNG
((1R,3S,5R)-2-(2- (3-acetyl-5-(2- cyclopropylpyrazo...)
Show SMILES CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc2cc(nn2c1)C1CC1
Show InChI InChI=1S/C31H27BrN8O3/c1-16(41)30-21-9-18(20-13-33-28-12-22(17-5-6-17)36-39(28)14-20)7-8-23(21)38(37-30)15-29(42)40-24-10-19(24)11-25(40)31(43)35-27-4-2-3-26(32)34-27/h2-4,7-9,12-14,17,19,24-25H,5-6,10-11,15H2,1H3,(H,34,35,43)/t19-,24-,25+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386724
PNG
((2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- ...)
Show SMILES CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc(Cl)cc(Br)n2)c2ccc(cc12)-c1cnc2cc(C)nn2c1
Show InChI InChI=1S/C28H23BrClFN8O3/c1-14-5-25-32-10-17(11-39(25)35-14)16-3-4-21-20(6-16)27(15(2)40)36-38(21)13-26(41)37-12-19(31)9-22(37)28(42)34-24-8-18(30)7-23(29)33-24/h3-8,10-11,19,22H,9,12-13H2,1-2H3,(H,33,34,42)/t19-,22+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386506
PNG
((2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-y...)
Show SMILES CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCCc2ccccc2)c2ccc(cc12)-c1cnc(C)nc1
Show InChI InChI=1S/C30H30FN5O3/c1-19(37)26-17-35(27-9-8-22(12-25(26)27)23-14-33-20(2)34-15-23)18-29(38)36-16-24(31)13-28(36)30(39)32-11-10-21-6-4-3-5-7-21/h3-9,12,14-15,17,24,28H,10-11,13,16,18H2,1-2H3,(H,32,39)/t24-,28+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386523
PNG
((2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-y...)
Show SMILES CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2C[C@H]2c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)nc1
Show InChI InChI=1S/C30H28ClFN6O3/c1-16(39)29-23-9-18(19-12-33-17(2)34-13-19)7-8-26(23)38(36-29)15-28(40)37-14-20(32)10-27(37)30(41)35-25-11-22(25)21-5-3-4-6-24(21)31/h3-9,12-13,20,22,25,27H,10-11,14-15H2,1-2H3,(H,35,41)/t20-,22+,25?,27+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386728
PNG
((2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1.5- ...)
Show SMILES CC(C)c1cccc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc3cc(C)nn3c2)n1
Show InChI InChI=1S/C31H31FN8O3/c1-17(2)24-6-5-7-27(34-24)35-31(43)26-12-22(32)15-38(26)29(42)16-39-25-9-8-20(11-23(25)30(37-39)19(4)41)21-13-33-28-10-18(3)36-40(28)14-21/h5-11,13-14,17,22,26H,12,15-16H2,1-4H3,(H,34,35,43)/t22-,26+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386745
PNG
((2S,4R)-1-(2-(3- acetyl-5-(1-(5- fluoropyrimidin- ...)
Show SMILES CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnn(c1)-c1ncc(F)cn1
Show InChI InChI=1S/C28H22BrF2N9O3/c1-15(41)26-20-7-16(17-9-34-40(12-17)28-32-10-19(31)11-33-28)5-6-21(20)39(37-26)14-25(42)38-13-18(30)8-22(38)27(43)36-24-4-2-3-23(29)35-24/h2-7,9-12,18,22H,8,13-14H2,1H3,(H,35,36,43)/t18-,22+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386759
PNG
(1-(2-((1R,3S,5R)- 3-((5'-acetyl-2'- chloro-2-fluor...)
Show SMILES CC(=O)c1ccc(Cl)c(c1)-c1cccc(NC(=O)[C@@H]2C[C@H]3C[C@H]3N2C(=O)Cn2nc(C(N)=O)c3sc(nc23)-c2cnc3cc(C)nn3c2)c1F
Show InChI InChI=1S/C34H27ClFN9O4S/c1-15-8-26-38-12-19(13-43(26)41-15)34-40-32-30(50-34)29(31(37)48)42-44(32)14-27(47)45-24-10-18(24)11-25(45)33(49)39-23-5-3-4-20(28(23)36)21-9-17(16(2)46)6-7-22(21)35/h3-9,12-13,18,24-25H,10-11,14H2,1-2H3,(H2,37,48)(H,39,49)/t18-,24-,25+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386760
PNG
(1-(2-((1R,3S,5R)- 3-((5'-acetyl-2'- chloro-2-fluor...)
Show SMILES CC(=O)c1ccc(Cl)c(c1)-c1cccc(NC(=O)[C@@H]2C[C@H]3C[C@H]3N2C(=O)Cn2nc(C(N)=O)c3sc(nc23)-c2cnc(C)nc2)c1F
Show InChI InChI=1S/C32H26ClFN8O4S/c1-14(43)16-6-7-21(33)20(8-16)19-4-3-5-22(26(19)34)38-31(46)24-10-17-9-23(17)42(24)25(44)13-41-30-28(27(40-41)29(35)45)47-32(39-30)18-11-36-15(2)37-12-18/h3-8,11-12,17,23-24H,9-10,13H2,1-2H3,(H2,35,45)(H,38,46)/t17-,23-,24+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM386761
PNG
((2S,4R)-1-(2-(3- acetyl-5- ((1S,4R)-2-(4- methoxyp...)
Show SMILES COc1ccc(cc1)N1C[C@@H]2CC[C@H]1C=C2c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(C)=O)c2c1
Show InChI InChI=1S/C35H34BrFN6O4/c1-20(44)34-28-14-21(27-16-25-8-6-22(27)17-41(25)24-9-11-26(47-2)12-10-24)7-13-29(28)43(40-34)19-33(45)42-18-23(37)15-30(42)35(46)39-32-5-3-4-31(36)38-32/h3-5,7,9-14,16,22-23,25,30H,6,8,15,17-19H2,1-2H3,(H,38,39,46)/t22-,23+,25-,30-/m0/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...


US Patent US10287301 (2019)

More data for this
Ligand-Target Pair
Displayed 1 to 50 (of 719 total )  |  Next  |  Last  >>
* indicates data uncertainty>20%